Chang H - Search Results

1

Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial.

Sabel MS, Kaufman CS, Whitworth P, Chang H, Stocks LH, Simmons R, Schultz M. Sabel MS, et al. Among authors: chang h. Ann Surg Oncol. 2004 May;11(5):542-9. doi: 10.1245/ASO.2004.08.003. Ann Surg Oncol. 2004. PMID: 15123465 Clinical Trial.

2

Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatment.

Chang HR, Glaspy J, Allison MA, Kass FC, Elashoff R, Chung DU, Gornbein J. Chang HR, et al. Cancer. 2010 Sep 15;116(18):4227-37. doi: 10.1002/cncr.25309. Cancer. 2010. PMID: 20549829 Clinical Trial.

3

ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.

Ping Z, Siegal GP, Harada S, Eltoum IE, Youssef M, Shen T, He J, Huang Y, Chen D, Li Y, Bland KI, Chang HR, Shen D. Ping Z, et al. Oncotarget. 2016 Dec 6;7(49):80655-80663. doi: 10.18632/oncotarget.13019. Oncotarget. 2016. PMID: 27811364 Free PMC article.

4

Histopathologic characteristics predicting HER-2/neu amplification in breast cancer.

Prati R, Apple SK, He J, Gornbein JA, Chang HR. Prati R, et al. Breast J. 2005 Nov-Dec;11(6):433-9. doi: 10.1111/j.1075-122X.2005.00125.x. Breast J. 2005. PMID: 16297088

5

Tumor proteomic profiling predicts the susceptibility of breast cancer to chemotherapy.

He J, Shen D, Chung DU, Saxton RE, Whitelegge JP, Faull KF, Chang HR. He J, et al. Int J Oncol. 2009 Oct;35(4):683-92. doi: 10.3892/ijo_00000380. Int J Oncol. 2009. PMID: 19724903 Clinical Trial.

6

Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.

Choi SH, Barsky SH, Chang HR. Choi SH, et al. Among authors: chang hr. Breast J. 2003 May-Jun;9(3):153-62. doi: 10.1046/j.1524-4741.2003.09304.x. Breast J. 2003. PMID: 12752622

7

Surgical treatment of breast cancer in previously augmented patients.

Karanas YL, Leong DS, Da Lio A, Waldron K, Watson JP, Chang H, Shaw WW. Karanas YL, et al. Among authors: chang h. Plast Reconstr Surg. 2003 Mar;111(3):1078-83; discussion 1084-6. doi: 10.1097/01.PRS.0000046667.56931.E1. Plast Reconstr Surg. 2003. PMID: 12621177

8

Predictors for contralateral prophylactic mastectomy in breast cancer patients.

Fu Y, Zhuang Z, Dewing M, Apple S, Chang H. Fu Y, et al. Among authors: chang h. Int J Clin Exp Pathol. 2015 Apr 1;8(4):3748-64. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26097557 Free PMC article.

9

Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?

Fu Y, Chung D, Cao MA, Apple S, Chang H. Fu Y, et al. Among authors: chang h. Ann Surg Oncol. 2014 Dec;21(13):4109-23. doi: 10.1245/s10434-014-3814-3. Epub 2014 Aug 1. Ann Surg Oncol. 2014. PMID: 25081336

10

Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometry.

He J, Gornbein J, Shen D, Lu M, Rovai LE, Shau H, Katz J, Whitelegge JP, Faull KF, Chang HR. He J, et al. Among authors: chang hr. Int J Oncol. 2007 Jan;30(1):145-54. Int J Oncol. 2007. PMID: 17143523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results